ClinicalTrials.Veeva

Menu

The Effect of Providing Free Samples of Generic Cardiovascular Medications to Physicians (SAMPLES)

Mass General Brigham logo

Mass General Brigham

Status

Unknown

Conditions

Hypertension
Hyperlipidemia

Treatments

Behavioral: Free Generic Samples (hydrochlorothiazide, simvastatin)

Study type

Interventional

Funder types

Other

Identifiers

NCT00761904
1K23HL090505-01 (U.S. NIH Grant/Contract)
08-001010

Details and patient eligibility

About

In this randomized controlled trial, we will provide primary care physicians with free samples of highly effective generic cardiovascular medications. We will test whether this intervention will stimulate cost-effective prescribing, reducing drug costs and improving adherence to essential cardiovascular medications.

Full description

Highly-effective generic cardiovascular medications are frequently underused, leading to greater overall drug costs and cost-related non-adherence. Interventions are needed to stimulate appropriate generic drug use without creating administrative or financial barriers to branded medications that may impede essential medication use.

The SAMPLES trial is a clustered, randomized controlled trial of the effect of providing physicians with free generic samples of hydrochlorothiazide for hypertensive patients and simvastatin for patients with hyperlipidemia. We will randomize 660 primary care physicians in Pennsylvania, clustered by physician practice, to receive free samples for both conditions or to receive no samples. We will use pharmacy claims of their patient population enrolled in a state-sponsored prescription drug assistance program to evaluate outcomes of interest. The primary outcomes are physician prescribing behavior (proportion of prescriptions that are generic), and patient adherence to chronic therapy. Secondary outcomes will include physician adherence to established guidelines (for anti-hypertensive regimens) and overall prescription drug costs. Primary analyses will be based on intention-to-treat principles.

This trial highlights a new and innovative approach to stimulate cost-effective prescribing. Free generic samples can reduce overall drug costs as well as out-of-pocket costs to the patient without sacrificing efficacy, and may result in improved adherence to essential cardiovascular medications. This intervention may also improve adherence to practice guidelines and improve the quality of care received. If found to be effective, this strategy could be utilized broadly by private insurers or government payers aiming to stimulate more cost-effective and higher-quality care.

Enrollment

660 estimated patients

Sex

All

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Primary care physicians receiving an existing academic detailing program in Pennsylvania

Exclusion criteria

  • Those with administrative policies stating they do not accept free samples

Trial design

Primary purpose

Health Services Research

Allocation

Randomized

Interventional model

Single Group Assignment

Masking

Single Blind

660 participants in 2 patient groups

receipt of free generic samples
Experimental group
Treatment:
Behavioral: Free Generic Samples (hydrochlorothiazide, simvastatin)
usual prescribing
No Intervention group

Trial contacts and locations

1

Loading...

Central trial contact

William H Shrank, MD MSHS; Amber Servi, BA

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems